Here's Why Corbus Pharmaceuticals Holdings Inc. Jumped Today

In response to upbeat results released from a phase 2 clinical trial, shares of Corbus Pharmaceuticals (NASDAQ: CRBP), a clinical-stage biotech focused on inflammatory and fibrotic diseases, jumped by 14% as of 11 a.m. EDT on Thursday.Corbus announced topline results from a 16-week phase 2 study evaluating its lead compound anabasum as a hopeful treatment for dermatomyositis, a rare disease that affects about 70,000 Americans each year.The study showed that patients who used anabasum show an improvement on the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) activity score of 9.3 points.

BING NEWS:
  • Emergent BioSolutions to cut 300 employees, shutter 2 facilities in restructuring launched under new CEO
    Just about two months into his CEO job at Emergent BioSolutions, Joseph Papa has laid out his turnaround plan for the CDMO-turned-biopharma company. | Merely about two months into his CEO job at ...
    05/1/2024 - 10:06 am | View Link
  • Pfizer Jumps On 'Massive' First-Quarter Upside Thanks To Paxlovid Surprise
    Pfizer stock surged Wednesday after the pharma giant walloped analysts' first-quarter earnings forecast and hiked its guidance.
    05/1/2024 - 9:14 am | View Link
  • Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
    AbbVie has two successors that could offset the losses from its blockbuster drug Humira. Meanwhile, UnitedHealth Group's CEO will testify on Capitol Hill.
    05/1/2024 - 1:40 am | View Link
  • Corbus Pharmaceuticals Holdings, Inc. (CRBP)
    April 24, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ ... Corbus Pharmaceuticals (NASDAQ:CRBP) jumped on Friday after announcing positive data from a small group ...
    04/30/2024 - 5:00 am | View Link
  • U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents
    The U.S. Supreme Court on Monday declined to hear a bid by Vanda Pharmaceuticals to revive patents for its sleep-disorder drug Hetlioz that were previously declared invalid in a dispute with generic ...
    04/22/2024 - 3:47 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News